Ibuprofeno Labesfal

Ibuprofen, the active ingredient in Ibuprofeno Labesfal, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for oral use. It treats pain, fever and inflammation in adults and children as appropriate.

GNH USA supplies Ibuprofeno Labesfal as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibuprofeno Labesfal, an NSAID, acts on the cyclooxygenase pathway to reduce prostaglandin synthesis and relieve symptoms in several common conditions.

- Pain: Provides symptomatic relief of mild to moderate nociceptive pain such as headache, dental pain, musculoskeletal aches, and dysmenorrhea. - Fever: Lowers elevated body temperature associated with viral or bacterial infections and other febrile states. - Inflammation: Reduces swelling and discomfort in conditions like arthritis, soft‑tissue injuries, and postoperative inflammation.

Adverse reactions may range from mild, transient events to serious, potentially life‑threatening conditions.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or mild abdominal pain. - Headache: transient tension‑type headache. - Dizziness or vertigo. - Skin reactions: mild rash or pruritus. - Elevated blood pressure in susceptible individuals.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding, which may present as melena or hematemesis. - Renal impairment, including acute kidney injury, especially in volume‑depleted patients. - Cardiovascular events such as myocardial infarction or stroke, particularly with high‑dose or prolonged use. - Severe hypersensitivity reactions, including anaphylaxis or Stevens‑Johnson syndrome.

Before using Ibuprofeno Labesfal, consider the following safety measures.

- Assess renal function: avoid use in patients with severe renal impairment. - Monitor gastrointestinal risk: use with caution in individuals with a history of ulcers or bleeding. - Evaluate cardiovascular status: limit use in patients with established heart disease or uncontrolled hypertension. - Review concomitant medications: avoid concurrent use with other NSAIDs, anticoagulants, or corticosteroids without medical supervision. - Pregnancy and lactation: discuss potential risks with a healthcare professional before use. - Store at ambient temperature: keep below 25 °C, retain in the original packaging, and protect from moisture and direct sunlight.

Ibuprofeno Labesfal may alter the efficacy or safety of several co‑administered medicines.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Selective COX‑2 inhibitors: additive gastrointestinal toxicity. - High‑dose aspirin: heightened renal and gastrointestinal adverse effects.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in antihypertensive effect and renal function. - Diuretics: may enhance nephrotoxic potential. - Lithium: ibuprofen can raise serum lithium levels, requiring monitoring.